18.02.2010
- Abbott has completed its €4.5 billion acquisition of Belgium-based Solvay Pharmaceuticals. The acquisition gives the U.S.-based healthcare company a large and complementary...
12.02.2010
- The European Commission gave Abbott the go ahead to buy Solvay's pharmaceutical business for $6.6 billion, with certain sales conditions. Because of concerns about competition...
09.02.2010
- Reuters is reporting that Abbott Laboratories is expected to win EU approval this week for its takeover of Solvay's drugs unit. Abbott announced its intention to buy out Solvay's...
22.01.2010
- Abbott Laboratories said it has agreed to acquire Israel-based Starlims Technologies for $123 million to boost its position in the global diagnostics market. The acquisition will...
11.12.2009
- Belgian drugs, chemicals and plastics maker Solvay said it would sell its drugs unit to U.S. partner Abbott Laboratories for €4.5 billion ($6.6 billion) in cash and reinvest in...
